OBORAVO MET 12.5/500MG TABLET

About OBORAVO MET 12.5/500MG TABLET

OBORAVO MET 12.5/500MG TABLET is a tablet from CIPLA LTD, available as 10 TABLETS. It contains EMPAGLIFLOZIN 12.5MG + METFORMIN 500MG.

Common uses: Type 2 diabetes control; reduces blood sugar when two medicines are needed together; may help protect heart and kidneys.

Take it with water exactly as your doctor has advised, and follow the label or your doctor on whether it should be taken before or after food.

OBORAVO MET 12.5/500MG TABLET is a prescription medicine: upload a valid doctor's prescription when you order, and our pharmacist checks it before dispatch.

Store it as directed on the pack, away from direct sunlight and moisture, and out of the reach of children.

Where other brands with the same composition (EMPAGLIFLOZIN 12.5MG + METFORMIN 500MG) are available, MedZoneAI shows them on this page so you can compare prices before you buy.

Uses of OBORAVO MET 12.5/500MG TABLET

• Type 2 diabetes control
• Reduces blood sugar when two medicines are needed together
• May help protect heart and kidneys

Side effects of OBORAVO MET 12.5/500MG TABLET

• Nausea or stomach upset
• Increased urination
• Thirst
• Genital infections
• Metal taste in mouth
• Dizziness

Precautions for OBORAVO MET 12.5/500MG TABLET

• Tell your doctor about kidney or liver problems
• Not for pregnancy or breastfeeding
• Inform about all other medicines
• Stay hydrated
• Avoid alcohol